Effects of triamcinolone acetonide, sodium hyaluronate, amikacin sulfate, and mepivacaine hydrochloride, alone and in combination, on morphology and matrix composition of lipopolysaccharide-challenged and unchallenged equine articular cartilage explants.

This is a study investigating how triamcinolone acetonide (TA), sodium hyaluronate (HA), amikacin sulfate (AS), and mepivacaine hydrochloride (MC) affect the structure and substance of horse articular cartilage, especially when the cartilage is affected by lipopolysaccharide (LPS). The goal is to understand the impact of these substances on cartilage health in hopes of developing more effective ways to support or repair it.

Research Methodology

• The study made use of 96 articular cartilage explants which were harvested from the femoropatellar joints of two adult horses.
• The explants were divided into two groups, one that was exposed to lipopolysaccharide (LPS), a substance that compromises the health of the cartilage, and another that was not (unchallenged group).
• Both groups were then subjected to treatments of triamcinolone acetonide (TA), sodium hyaluronate (HA), amikacin sulfate (AS), and mepivacaine hydrochloride (MC) individually or in combination.
• Democratic methyl-methylene blue assay was used to analyze the cartilage for glycosaminoglycan (GAG) content, an important compound in the cartilage matrix.
• Histomorphometric scanning was conducted to evaluate the changes in morphology and density of chondrocytes (lacunae) in three specific cartilage zones.

Research Findings

• The LPS challenging process resulted in an increased count of pyknotic nuclei (a sign of cell death) and empty lacunae (spaces where chondrocytes are missing).
• Treatment with TA or HA significantly reduced the occurrence of empty lacunae in both the LPS-challenged and unchallenged explants, indicating a protective effect on the cartilage.
• However, treatments with AS or MC resulted in more empty lacunae in the unchallenged explants, suggesting that these treatments might have harmful effects on the cartilage. But these adverse effects were reduced when TA was introduced.
• Treatment with MC led to an increase in not only empty lacunae but also pyknotic nuclei. This effect worsened when used in combination with LPS, and TA could not reverse it.
• There was no significant difference in GAG content between LPS-challenged and unchallenged explants, or among different treatments.

Conclusion

• The study concludes that TA or HA treatments can support chondrocyte morphology and protect cartilage against toxic effects from LPS, AS, and MC. This discovery informs potential therapeutic treatments for horses suffering from articular cartilage issues.